3 months ago
TGTX
AnalystsMayank MamtaniMayank Mamtani's Stock Forecasts
AnalystsMayank Mamtani
Analyst Ranking
Top 3%
#126 out of 4560 analysts
Average Return
+36.21%
Win Rate
42%38 out of 91
Risk vs Reward
Poor
Good
Mayank Mamtani's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +1,295.56% | $13.05 | $182.12 | 2020-03-27 - 2021-03-26 | Strong Buy |
Novavax IncNVAX | +946.95% | $19.83 | $207.61 | 2020-04-24 - 2021-04-23 | Strong Buy |
Tg Therapeutics IncTGTX | +534.38% | $4.13 | $26.20 | 2022-06-13 - 2023-06-12 | Strong Buy |
Cymabay Therapeutics IncCBAY | +382.37% | $1.90 | $9.17 | 2022-05-18 - 2023-05-17 | Strong Buy |
Altimmune IncALT | +208.98% | $2.45 | $7.57 | 2023-11-09 - 2024-04-23 | Strong Buy |
Mayank Mamtani Analyst Color
Get additional color on Mayank Mamtani's coverage of popular stocks
8 months ago
CBAY
a year ago
NVAX
a year ago
CKPT
2 years ago
ALT
Mayank Mamtani's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cognition Therapeutics IncCGTX | 1 | Strong Buy | $5.00 | +150.00% | Reiterates | a month ago |
Altimmune IncALT | 6 | Strong Buy | $20.00 | +164.20% | Reiterates | a month ago |
Madrigal Pharmaceuticals IncMDGL | 6 | Hold | $270.00 | +23.64% | Upgrades | a month ago |
Cymabay Therapeutics IncCBAY | 5 | Hold | $32.50 | +0.06% | Downgrades | 2 months ago |
Tg Therapeutics IncTGTX | 10 | Strong Buy | $29.00 | +103.51% | Maintains | 3 months ago |
Vaxart IncVXRT | 4 | Strong Buy | $2.00 | +168.46% | Upgrades | 3 months ago |
Checkpoint Therapeutics IncCKPT | 3 | Strong Buy | $4.00 | +178.75% | Maintains | 4 months ago |
Ngm Biopharmaceuticals IncNGM | 4 | Strong Buy | $3.50 | +127.27% | Maintains | 5 months ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $66.00 | +0.66% | Initiates Coverage On | 6 months ago |
Scilex Holding CoSCLX | 1 | Strong Buy | $4.00 | +309.42% | Initiates Coverage On | 6 months ago |
Intercept Pharmaceuticals IncICPT | 8 | Hold | $19.00 | 0.00% | Downgrades | 7 months ago |
Denali Therapeutics IncDNLI | 1 | Strong Buy | $38.00 | +135.88% | Initiates Coverage On | 8 months ago |
Novavax IncNVAX | 10 | Strong Buy | $15.00 | +258.00% | Upgrades | 8 months ago |
Arrowhead Pharmaceuticals IncARWR | 5 | Strong Buy | $55.00 | +131.29% | Reiterates | 9 months ago |
Trevi Therapeutics IncTRVI | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
X4 Pharmaceuticals IncXFOR | 3 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Agenus IncAGEN | 1 | Strong Buy | $160.00 | N/A | Reiterates | a year ago |
Gritstone Bio IncGRTS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Spectrum Pharmaceuticals IncSPPI | 4 | Hold | $1.00 | N/A | Downgrades | a year ago |
Gain Therapeutics IncGANX | 3 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Cassava Sciences IncSAVA | 3 | Strong Buy | $44.00 | N/A | Maintains | 2 years ago |
Fortress Biotech IncFBIO | 1 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Lineage Cell Therapeutics IncLCTX | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Inmune Bio IncINMB | 2 | Hold | $7.00 | N/A | Downgrades | 2 years ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $450.00 | N/A | Maintains | 2 years ago |
Korro Bio IncKRRO | 1 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Allena Pharmaceuticals IncALNAQ | 3 | Hold | $0.50 | N/A | Downgrades | 2 years ago |
Scorpius Holdings IncSCPX | 1 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Seelos Therapeutics IncSEEL | 2 | Strong Buy | $120.00 | N/A | Maintains | 2 years ago |
Mustang Bio IncMBIO | 3 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Biovie IncBIVI | 1 | Strong Buy | $27.00 | N/A | Maintains | 2 years ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Hold | $77.00 | N/A | Downgrades | 3 years ago |
Acasti Pharma IncACST | 2 | Strong Buy | $96.00 | N/A | Upgrades | 4 years ago |
Galmed Pharmaceuticals LtdGLMD | 3 | Hold | $120.00 | N/A | Downgrades | 4 years ago |
Galectin Therapeutics IncGALT | 1 | Strong Buy | $4.00 | N/A | Maintains | 4 years ago |
Imv IncIMVIQ | 2 | Hold | $30.00 | N/A | Downgrades | 4 years ago |
Liberty Media CorpFWONK | 1 | Strong Buy | $39.00 | N/A | Maintains | 4 years ago |
Medicinova IncMNOV | 1 | Strong Buy | $11.00 | N/A | Maintains | 4 years ago |
Genfit SaGNFT | 1 | Strong Buy | $34.00 | N/A | Maintains | 4 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.